BiotechTube
Home/Pipeline/MBX‑SD‑201

MBX‑SD‑201

Acute Clostridioides difficile infection

Phase 1Active

Key Facts

Indication
Acute Clostridioides difficile infection
Phase
Phase 1
Status
Active
Company
MyBiotics

About MyBiotics

Israeli microbiome biotech delivering AI‑enhanced live bacterial therapeutics for gut‑related diseases.

View full company profile

Therapeutic Areas

Infectious DiseasesGastroenterologyOncologyWomen's Health

Other Acute Clostridioides difficile infection Drugs

DrugCompanyPhase
MBX‑SD‑202MyBioticsPhase 1